Alcohol & Drug Abuse

Issue Code: ALC

🤖

AI Overview

Alcohol & Drug Abuse is one of the 79 issue categories tracked under the Lobbying Disclosure Act. With $30.4M in total lobbying spend across 2,282 filings, it ranks among the actively lobbied policy areas in Washington. The money flowing into this issue reflects how much is at stake for the industries involved.

$30.4M
Total Lobbying Spend
2,282
Filings
50
Top Clients

Spending by Year

YearSpendingFilings
2018$4.4M338
2019$3.6M314
2020$3.8M277
2021$4.0M289
2022$4.1M338
2023$3.9M266
2024$3.0M234
2025$3.7M226

Biggest Spenders

Top Firms

What They Lobby For

  • Controlled Substance act improvements. Opioid overdose death reduction. Alprazolam rescheduling.
  • Educating congressional and administration officials on data analytics and federal programs.
  • Public Law 114-198, Comprehensive Addiction and Recovery Act (CARA); and policies to address the treatment of opioid/alcohol/drug addiction and mental-health related issues.
  • Working to close loop holes that would permit tobacco products from being accessible to and used by kids. Specifically working on related riders in federal appropriation bills.
  • Appropriations and authorization for programs related to children and families affected by grief and addiction.
  • Working to make it easier to get Medicare/Medicaid coverage for a medical device that eases patients off of opioids and into treatment.
  • National Drug Abuse Crisis and related bills. 42 CFR Part 2 - advocating to align 42 CFR Part 2 (substance use privacy regulations) with HIPAA to allow appropriate access to patient information that
  • Tracking pharmaceuticals throughout the supply chain
  • Anti-Doping efforts. FY 2018 Funding.
  • Anti-Doping Issues. H.R.2651: Horseracing Integrity Act of 2017.

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.